Cargando…
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
BACKGROUND: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports of aluminium related neurological and bone disease began to appear. Available historical evidence h...
Autores principales: | Mudge, David W, Johnson, David W, Hawley, Carmel M, Campbell, Scott B, Isbel, Nicole M, van Eps, Carolyn L, Petrie, James JB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107169/ https://www.ncbi.nlm.nih.gov/pubmed/21569446 http://dx.doi.org/10.1186/1471-2369-12-20 |
Ejemplares similares
-
The impact of automated eGFR reporting and education on nephrology service referrals
por: Noble, Euan, et al.
Publicado: (2008) -
Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
por: Pepper, Ruth, et al.
Publicado: (2011) -
Life-threatening adenovirus infection in a kidney transplant recipient
por: Barraclough, Katherine, et al.
Publicado: (2009) -
Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
por: Mudge, David W, et al.
Publicado: (2009) -
Clinical excellence in nephrology: Examples from the published literature
por: Geetha, Duvuru, et al.
Publicado: (2015)